Related Experiment Videos
A simple model to predict blood-brain barrier permeation from 3D molecular fields
Frédéric Ooms1, Peter Weber, Pierre Alain Carrupt
1Institut de Chimie Thérapeutique, Section de Pharmacie, BEP, Université de Lausanne, CH-1015, Lausanne, Switzerland.
Biochimica Et Biophysica Acta
|June 27, 2002
Summary
This study developed a predictive model for blood-brain barrier (BBB) permeation using molecular descriptors. The model aids in understanding how molecular properties influence BBB passage and facilitates virtual screening of new chemicals.
Area of Science:
- Computational chemistry
- Pharmacokinetics
- Medicinal chemistry
Background:
- The blood-brain barrier (BBB) restricts the passage of many molecules into the brain.
- Predicting BBB permeation is crucial for developing effective central nervous system drugs.
- Understanding molecular properties that govern BBB transport is essential for drug design.
Purpose of the Study:
- To develop a quantitative model for predicting blood-brain barrier permeation.
- To identify key molecular descriptors influencing BBB penetration.
- To enable virtual screening of novel chemical entities for BBB permeability.
Main Methods:
- Utilized four-component partial least squares discriminant analysis (PLS).
- Employed descriptors derived from 3D molecular fields, transformed by VolSurf into 1D descriptors.
- Correlated descriptors with experimentally measured blood-brain partitioning ratios (log C(brain)/C(blood)) in rats.
Main Results:
- A robust PLS model was established for predicting BBB permeation.
- The model highlights specific molecular properties that significantly impact BBB passage.
- The developed model demonstrated utility in assessing potential BBB penetration.
Conclusions:
- The developed PLS model effectively predicts blood-brain barrier permeation.
- The model provides insights into the molecular characteristics governing BBB transport.
- This approach supports efficient virtual screening for CNS-targeted drug discovery.